TY  - CONF 
AU  - Sastre Moral, José Luis
PY  - 2014
SN  - 0390-6078
UR  - http://hdl.handle.net/20.500.11940/1081
LA  - eng
TI  - The decline of BCR-ABL/GUS ratio in CML patients treated upfront with nilotinib shows a rapid descent during the first trimester, and the responses are similar to those achieved with ABL as control
VL  - 99
ER  -